REZOLUTE, INC. Interest Payable
REZOLUTE, INC. (RZLT) had Interest Payable of $800.00 thousand as of 2019-01-31, per its 10-K filed 2019-09-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2019-09-10
- 2019-01-31: Interest Payable $800.00K.
- 2013-03-31: Interest Payable $298.52K.
- 2012-06-30: Interest Payable $110.12K.
| Period end | Interest Payable |
|---|---|
| 2019-01-31 | $800.00K 10-K · filed 2019-09-10 |
| 2013-03-31 | $298.52K 10-Q · filed 2013-05-15 |
| 2012-06-30 | $110.12K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |